RAB29 and Parkinson disease: Several earlier studies alluded to the possibility of Rab29 and LRRK2 acting in converging pathways, by demonstrating epistatic interactions between polymorphisms in the LRRK2 and Rab29 genes that increase PD risk [39,40].